Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer

por Gourdin, Theodore, Sonpavde, Guru
Publicado 2018

FRI263 Challenges In Management Of Biochemically Silent Pheochromocytoma

por Gannamani, Gowtham, Gourdin, Theodore Stewart, Fernandes, Jyotika Kanwar
Publicado 2023

Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration‐resistant prostate cancer

por Bray, Alexander W., Duan, Rong, Malalur, Pannaga, Drusbosky, Leylah M., Gourdin, Theodore S., Hill, Elizabeth G., Lilly, Michael B.
Publicado 2022

Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma

por Jun, Tomi, Hahn, Noah M, Sonpavde, Guru, Albany, Constantine, MacVicar, Gary R, Hauke, Ralph, Fleming, Mark, Gourdin, Theodore, Jana, Bagi, Oh, William K, Taik, Patricia, Wang, Huan, Varadarajan, Ajay Ramakrishnan, Uzilov, Andrew, Galsky, Matthew D
Publicado 2022

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis

por Apolo, Andrea B, Ellerton, John A, Infante, Jeffrey R, Agrawal, Manish, Gordon, Michael S, Aljumaily, Raid, Gourdin, Theodore, Dirix, Luc, Lee, Keun-Wook, Taylor, Matthew H, Schöffski, Patrick, Wang, Ding, Ravaud, Alain, Manitz, Juliane, Pennock, Gregory, Ruisi, Mary, Gulley, James L, Patel, Manish R
Publicado 2020

First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma

por Strauss, Julius, Deville, Jean-Laurent, Sznol, Mario, Ravaud, Alain, Maruzzo, Marco, Pachynski, Russell K, Gourdin, Theodore S, Maio, Michele, Dirix, Luc, Schlom, Jeffrey, Donahue, Renee N, Tsai, Yo-Ting, Wang, XiaoZhe, Vugmeyster, Yulia, Beier, Frank, Seebeck, Joerg, Schroeder, Andreas, Chennoufi, Sarah, Gulley, James L
Publicado 2023